Pieter Leyssen merges Virus with Rhinovirus in his study. In his articles, Pieter Leyssen combines various disciplines, including Virology and Viral replication. As part of his studies on Viral replication, Pieter Leyssen often connects relevant subjects like Genetics. As part of his studies on Genetics, Pieter Leyssen often connects relevant subjects like Antiviral drug. He conducted interdisciplinary study in his works that combined Biochemistry and Pharmacology. In his works, he conducts interdisciplinary research on Pharmacology and Biochemistry. He merges Gene with Molecular biology in his research. He applies his multidisciplinary studies on Molecular biology and Gene in his research. Pieter Leyssen combines RNA and Polymerase in his research.
His work on Virology is being expanded to include thematically relevant topics such as Enterovirus. He carries out multidisciplinary research, doing studies in Biochemistry and Pharmacology. He performs integrative study on Pharmacology and Biochemistry. He integrates many fields, such as Gene and Enzyme, in his works. He brings together Enzyme and Gene to produce work in his papers. He combines topics linked to Genetics with his work on Viral replication. He regularly links together related areas like Viral replication in his Genetics studies. Borrowing concepts from Virus, Pieter Leyssen weaves in ideas under In vitro. Stereochemistry and Organic chemistry are two areas of study in which Pieter Leyssen engages in interdisciplinary research.
The research on Vero cell, EC50, Potency, Cytotoxic T cell and Cytotoxicity is part of his In vitro project. His study ties his expertise on Virology together with the subject of Vero cell. His Virology study frequently draws connections between related disciplines such as Titer. Cytotoxic T cell is often connected to In vitro in his work. He connects Cytotoxicity with Virus in his study. Pieter Leyssen merges many fields, such as Virus and Viral entry, in his writings. He is investigating Viral life cycle and Viral entry as part of his examination of Viral replication. In his research, Pieter Leyssen performs multidisciplinary study on Viral life cycle and Viral replication. Within the field of Protease and Polymerase Pieter Leyssen studies Enzyme.
Pieter Leyssen integrates many fields in his works, including Virology and Viral replication. Viral replication and Virology are two areas of study in which he engages in interdisciplinary research. He integrates many fields, such as Biochemistry and Receptor, in his works. He merges Receptor with Biochemistry in his study. His research on In vitro frequently links to adjacent areas such as Vero cell. His Vero cell study typically links adjacent topics like In vitro. Pieter Leyssen integrates several fields in his works, including Virus and Protease. Pieter Leyssen performs integrative Protease and Gene research in his work. In his research, Pieter Leyssen performs multidisciplinary study on Gene and Molecular biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
Linlin Zhang;Daizong Lin;Yuri Kusov;Yong Nian.
Journal of Medicinal Chemistry (2020)
Perspectives for the Treatment of Infections with Flaviviridae
P Leyssen;E De Clercq;J Neyts.
Clinical Microbiology Reviews (2000)
Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein.
Jeroen R.P.M. Strating;Jeroen R.P.M. Strating;Lonneke van der Linden;Lonneke van der Linden;Lucian Albulescu;Lucian Albulescu;Joëlle Bigay.
Cell Reports (2015)
Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral
Leen Delang;Nidya Segura Guerrero;Ali Tas;Gilles Quérat.
Journal of Antimicrobial Chemotherapy (2014)
Bioactivity-Based Molecular Networking for the Discovery of Drug Leads in Natural Product Bioassay-Guided Fractionation
Louis-Félix Nothias;Louis-Félix Nothias;Louis-Félix Nothias;Mélissa Nothias-Esposito;Mélissa Nothias-Esposito;Ricardo da Silva;Ricardo da Silva;Mingxun Wang;Mingxun Wang.
Journal of Natural Products (2018)
Molecular strategies to inhibit the replication of RNA viruses
Pieter Leyssen;Erik De Clercq;Johan Neyts.
Antiviral Research (2008)
Poly(I)-Poly(C12U) but Not Ribavirin Prevents Death in a Hamster Model of Nipah Virus Infection
M. C. Georges-Courbot;H. Contamin;C. Faure;P. Loth.
Antimicrobial Agents and Chemotherapy (2006)
Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development.
Leen Delang;Jan Paeshuyse;Inge Vliegen;Pieter Leyssen.
Hepatology (2009)
Favipiravir (T-705) inhibits in vitro norovirus replication.
J Rocha-Pereira;Dirk Jochmans;Kai Dallmeier;Pieter Leyssen.
Biochemical and Biophysical Research Communications (2012)
A Novel, Broad-Spectrum Inhibitor of Enterovirus Replication That Targets Host Cell Factor Phosphatidylinositol 4-Kinase IIIβ
Hilde M van der Schaar;Pieter Leyssen;Hendrik Jan Thibaut;Armando De Palma.
Antimicrobial Agents and Chemotherapy (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Rega Institute for Medical Research
Rega Institute for Medical Research
Aix-Marseille University
Institut de Chimie des Substances Naturelles
Rega Institute for Medical Research
Utrecht University
KU Leuven
National Tsing Hua University
KU Leuven
Aix-Marseille University
National Institutes of Health
Indian Institute of Technology Bombay
National Research Council (CNR)
Institute Curie
NTT (Japan)
United States Department of Agriculture
Université Côte d'Azur
Argonne National Laboratory
University of Campania "Luigi Vanvitelli"
University of Oslo
University of Edinburgh
Goethe University Frankfurt
Binghamton University
University of Illinois at Chicago
Virginia Mason Medical Center
Australian National University